ICCI Symposium 2020 4 Aug, 2020 02:08 AM
COVID-19 update: Due to concerns about COVID-19 and with the goal of increasing social distancing, the ICCI Annual Cancer Research Symposium scheduled for May 21 has been cancelled.
COVID-19 update: Due to concerns about COVID-19 and with the goal of increasing social distancing, the ICCI Annual Cancer Research Symposium scheduled for May 21 has been cancelled.
The Institute for Comparative Cancer Investigation (ICCI) at the University of Guelph facilitates translational oncology research in companion animals at the OVC Mona Campbell Centre for Animal Cancer by managing clinical trials and the Companion Animal Tumour Sample Bank (CATSB). Our goals: to advance the understanding of cancer and improve treatment options to benefit both companion animal and human cancer patients.
Launched in 2007, the institute is the first of its kind in Canada, combining the expertise of researchers in basic cancer biology and clinicians in veterinary medicine to take an integrated approach to cancer studies that cannot easily be matched in human research settings. The ICCI is dedicated to furthering the understanding of the cancer for the benefit of all species, including humans.
A key component of this groundbreaking initiative is the establishment of a world-class Animal Cancer Centre in the OVC Health Sciences Centre. The centre is dedicated to cancer diagnosis, treatment, teaching and clinical research.
ICCI Team (Left to Right):
(left photo) Dr. Paul Woods (Co-Director), Dr. Kaya Skowronski (Previous Tumour Bank Coordinator); Dr. Vicky Sabine (Clinical Research Coordinator), Dr. Michelle Oblak (Co-Assistant Director), Dr. Geoff Wood (Co-Assistant Director) and Dr. Brenda Coomber (Co-Director); (right photo) Deirdre Stuart (Current Tumour Bank Coordinator).
Wright, T., Brisson, B. A., Wood, G. A., Oblak, M., Mutsaers, A. J., Sabine, V., Skowronski, K., Belanger, C., Tiessen, A., & Bienzle, D. (2019). Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs. Cytometry. Part A : the journal of the International Society for Analytical Cytology, 95(9), 997–1007. https://doi.org/10.1002/cyto.a.23847
Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs. Funded partly by Pet Trust.
Craig, K., Wood, G. A., Keller, S. M., Mutsaers, A. J., & Wood, R. D. (2019). MicroRNA profiling in canine multicentric lymphoma. PloS one, 14(12), e0226357. https://doi.org/10.1371/journal.pone.0226357
MicroRNA profiling in canine multicentric lymphoma. Funded partly by Pet Trust.
Parissenti, A. M., Pritzker, L. B., Guo, B., Narendrula, R., Wang, S. X., Lin, L. L., Pei, J., Skowronski, K., Bienzle, D., Woods, J. P., Pritzker, K., & Coomber, B. L. (2019). RNA disruption indicates CHOP therapy efficacy in canine lymphoma. BMC veterinary research, 15(1), 453. https://doi.org/10.1186/s12917-019-2189-x
RNA disruption indicates CHOP therapy efficacy in canine lymphoma. Funded partly by Pet Trust.
Deravi, N., Berke, O., Woods, J. P., & Bienzle, D. (2017). Specific immunotypes of canine T cell lymphoma are associated with different outcomes. Veterinary immunology and immunopathology, 191, 5–13. https://doi.org/10.1016/j.vetimm.2017.07.008
Weidner, N., Woods, J. P., Conlon, P., Meckling, K. A., Atkinson, J. L., Bayle, J., Makowski, A. J., Horst, R. L., & Verbrugghe, A. (2017). Influence of Various Factors on Circulating 25(OH) Vitamin D Concentrations in Dogs with Cancer and Healthy Dogs. Journal of veterinary internal medicine, 31(6), 1796–1803. https://doi.org/10.1111/jvim.14834
Calvalido, J., Wood, G. A., Mutsaers, A. J., Wood, D., Sears, W., & Woods, J. P. (2016). Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs. Veterinary immunology and immunopathology, 182, 106–114. https://doi.org/10.1016/j.vetimm.2016.10.009